CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Isis Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 14, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 14, 2022Methods For Modulating C9Orf72 Expression2
Jun 10, 2020Linkage Modified Gapped Oligomeric Compounds And Uses Thereof1
Apr 29, 2020Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase1
Dec 26, 2018Modulation Of Alpha Synuclein Expression1
Aug 15, 2018Modulation Of Ube3A-Ats Expression1
Feb 7, 2018Modulation Of Apolipoprotein Ciii (Apociii) Expression2
Nov 15, 2017Modulation Of Rna By Repeat Targeting1

Top competitors of Isis Pharmaceuticals

Top competitors of Isis Pharmaceuticals based on patent oppositions.